SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-043424
Filing Date
2024-04-10
Accepted
2024-04-10 17:13:29
Documents
2
Period of Report
2024-04-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1628
2 EX-24.1 nexi-ex24_1.htm EX-24.1 13257
  Complete submission text file 0000950170-24-043424.txt   16408
Mailing Address C/O FRESH TRACKS THERAPEUTICS, INC. 2000 CENTRAL AVENUE, SUITE 100 BOULDER CO 80301
Business Address
Marchio Albert N II (Reporting) CIK: 0001196054 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40045 | Film No.: 24836565

Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)